TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Electronic Alert System for In-Hospital Acute Kidney Injury: A Randomized, Controlled Trial
Brief Summary: This study will randomize hospitalized patients with acute kidney injury (AKI) to usual care, or an electronic alert intervention. The electronic alert will be in the form of a text page that will be sent to the covering clinician and unit pharmacist once per patient with AKI at the time lab results are uploaded. The investigators hypothesize that such an alert will improve outcomes in these patients.


Options:
A: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
B: Arm Label: Family Decision Support; Type: EXPERIMENTAL; Interventions: Behavioral: Family Decision Support | Arm Label: Clinical Decision Support; Type: EXPERIMENTAL; Interventions: Behavioral: Clinician Decision Support | Arm Label: Family DS+ Clinician DS; Type: EXPERIMENTAL; Interventions: Behavioral: Family Decision Support, Behavioral: Clinician Decision Support, Other: Family Decision Support and Clinician Decision Support | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: BEHAVIORAL; Name: Family Decision Support; Assigned to Arm(s): Family DS+ Clinician DS, Family Decision Support | Intervention Type: BEHAVIORAL; Name: Clinician Decision Support; Assigned to Arm(s): Clinical Decision Support, Family DS+ Clinician DS | Intervention Type: OTHER; Name: Family Decision Support and Clinician Decision Support; Assigned to Arm(s): Family DS+ Clinician DS | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Alert; Type: EXPERIMENTAL; Interventions: Other: Alert | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alert; Assigned to Arm(s): Alert
D: Arm Label: dashboard team care intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Dashboard Intervention | Arm Label: usual diabetes team control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Diabetes Care | Intervention Type: BEHAVIORAL; Name: Diabetes Dashboard Intervention; Assigned to Arm(s): dashboard team care intervention | Intervention Type: BEHAVIORAL; Name: Usual Diabetes Care; Assigned to Arm(s): usual diabetes team control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Electronic Alert System for In-Hospital Acute Kidney Injury: A Randomized, Controlled Trial
Brief Summary: This study will randomize hospitalized patients with acute kidney injury (AKI) to usual care, or an electronic alert intervention. The electronic alert will be in the form of a text page that will be sent to the covering clinician and unit pharmacist once per patient with AKI at the time lab results are uploaded. The investigators hypothesize that such an alert will improve outcomes in these patients.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: iChoose Kidney Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: iChoose Kidney Decision Aid | Intervention Type: BEHAVIORAL; Name: iChoose Kidney Decision Aid; Assigned to Arm(s): iChoose Kidney Decision Aid
B: Arm Label: Sun Protection Education; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based sun protection education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based sun protection education; Assigned to Arm(s): Sun Protection Education
C: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Health Communication Application; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Health Communication Application | Intervention Type: BEHAVIORAL; Name: Interactive Health Communication Application; Assigned to Arm(s): Health Communication Application
D: Arm Label: Alert; Type: EXPERIMENTAL; Interventions: Other: Alert | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alert; Assigned to Arm(s): Alert

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Brief Summary: To compare the efficacy of 2 fixed doses of brexpiprazole with placebo in participants with agitation associated with dementia of the Alzheimer's type.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Arm Label: Brexpiprazole 1 mg; Type: EXPERIMENTAL; Interventions: Drug: Brexpiprazole, OPC-34712 | Arm Label: Brexpiprazole 2 mg; Type: EXPERIMENTAL; Interventions: Drug: Brexpiprazole, OPC-34712 | Intervention Type: DRUG; Name: Brexpiprazole, OPC-34712; Assigned to Arm(s): Brexpiprazole 1 mg, Brexpiprazole 2 mg | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Brexpiprazole, OPC-34712 | Arm Label: Brexpiprazole (flexible dose range 0.5 to 2 mg); Type: EXPERIMENTAL; Interventions: Drug: Brexpiprazole, OPC-34712 | Intervention Type: DRUG; Name: Brexpiprazole, OPC-34712; Assigned to Arm(s): Brexpiprazole (flexible dose range 0.5 to 2 mg), Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pimavanserin 40 mg; Type: EXPERIMENTAL; Interventions: Drug: Pimavanserin tartrate | Intervention Type: DRUG; Name: Pimavanserin tartrate; Assigned to Arm(s): Pimavanserin 40 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Sit-Stand Workstations on Physical Activity in Sedentary Office Workers: A Randomized Crossover Trial
Brief Summary: The purpose of this study was to determine whether the installation of sit-stand work stations could lead to decreased sedentary time and increased physical activity during the workday among sedentary office workers.


Options:
A: Arm Label: Reduction in sitting time; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Arm Label: Increase in sit-to-stand transitions; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Intervention Type: BEHAVIORAL; Name: Sedentary behavior; Assigned to Arm(s): Increase in sit-to-stand transitions, Reduction in sitting time
B: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
C: Arm Label: Move; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Move | Arm Label: Stand & Move; Type: EXPERIMENTAL; Interventions: Device: Sit-Stand workstation, Behavioral: Move | Intervention Type: DEVICE; Name: Sit-Stand workstation; Assigned to Arm(s): Stand & Move | Intervention Type: BEHAVIORAL; Name: Move; Assigned to Arm(s): Move, Stand & Move
D: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Sit-Stand Workstations on Physical Activity in Sedentary Office Workers: A Randomized Crossover Trial
Brief Summary: The purpose of this study was to determine whether the installation of sit-stand work stations could lead to decreased sedentary time and increased physical activity during the workday among sedentary office workers.


Options:
A: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk
B: Arm Label: Lifestyle change; Type: EXPERIMENTAL; Interventions: Behavioral: Reduction of sedentary time by breaking it with low intensity physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reduction of sedentary time by breaking it with low intensity physical activity; Assigned to Arm(s): Lifestyle change
C: Arm Label: Treadmill workstation; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill workstation, Behavioral: Health talk | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Behavioral: Health talk | Intervention Type: BEHAVIORAL; Name: Treadmill workstation; Assigned to Arm(s): Treadmill workstation | Intervention Type: BEHAVIORAL; Name: Health talk; Assigned to Arm(s): Control group, Treadmill workstation
D: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Sit-Stand Workstations on Physical Activity in Sedentary Office Workers: A Randomized Crossover Trial
Brief Summary: The purpose of this study was to determine whether the installation of sit-stand work stations could lead to decreased sedentary time and increased physical activity during the workday among sedentary office workers.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sit-stand workstation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-stand workstation; Assigned to Arm(s): Intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
C: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: A workplace "sit less and move more" web-based program for Spanish office employees | Arm Label: Active comparison group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparison group | Intervention Type: BEHAVIORAL; Name: A workplace "sit less and move more" web-based program for Spanish office employees; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Active Comparison group; Assigned to Arm(s): Active comparison group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Two Community Based Screening Strategies for Severe Acute Malnutrition in Children Aged 6-59 Months in the Mirria District, Niger
Brief Summary: The objective of this study is to determine the efficacity of a community strategy for screening children 06-59 months old for Severe Acute Malnutrition (SAM) conducted by their mothers' compared with a community screening strategy conducted by Community Health Workers.


Options:
A: Arm Label: Micronutrient Sprinkles; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders (Sprinkles) | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders (Sprinkles); Assigned to Arm(s): Micronutrient Sprinkles
B: Arm Label: Zalewa; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Ligowe and Magaleta; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Neno District Hospital and Neno Parish; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Matope; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Matandani and Nsambe; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Luwani, Nkula, and Midzemba; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Intervention Type: BEHAVIORAL; Name: Household model; Assigned to Arm(s): Ligowe and Magaleta, Luwani, Nkula, and Midzemba, Matandani and Nsambe, Matope, Neno District Hospital and Neno Parish, Zalewa
C: Arm Label: nothing at home level; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home management of malaria; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Arm Label: Home management of malaria and pneumonia; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Intervention Type: OTHER; Name: home/community case management; Assigned to Arm(s): Home management of malaria, Home management of malaria and pneumonia
D: Arm Label: Screening by community health workers; Type: ACTIVE_COMPARATOR; Interventions: Other: Active comparator: Screening by community health workers | Arm Label: Screening by mothers; Type: EXPERIMENTAL; Interventions: Other: Screening by mothers | Intervention Type: OTHER; Name: Screening by mothers; Assigned to Arm(s): Screening by mothers | Intervention Type: OTHER; Name: Active comparator: Screening by community health workers; Assigned to Arm(s): Screening by community health workers

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.
Brief Summary: For patients hospitalized with acute decompensated heart failure,volume removal remains the primary therapeutic objective. The current standard of care remains loop diuretics.The high likelihood of readmissions and poor outcomes highlights the need to examine and improve in-hospital protocols for these patients. Ultrafiltration allows for greater volume removal, less neurohormonal stimulation and greater sodium removal.However it is associated with increased costs, line complications, and relative immobility during treatment. Tolvaptan in addition to diuretic therapy has been shown to improve the amount of volume removed compared to diuretic alone.

The study proposes to compare the strategy of adding tolvaptan to usual care with ultrafiltration as primary mode of therapy in acute decompensated HF(ADHF) patients.

Hypothesis: addition of tolvaptan to usual care for hospitalized HF patients will result in:

* greater volume and weight reduction compared with usual care
* similar efficacy outcomes compared with ultrafiltration, with less complications of therapy


Options:
A: Arm Label: Continuous Furosemide Infusion; Type: N/A; Interventions: Drug: Continuous Furosemide Infusion | Arm Label: Intermittent Furosemide Infusion; Type: N/A; Interventions: Drug: Intermittent Furosemide Infusion | Intervention Type: DRUG; Name: Continuous Furosemide Infusion; Assigned to Arm(s): Continuous Furosemide Infusion | Intervention Type: DRUG; Name: Intermittent Furosemide Infusion; Assigned to Arm(s): Intermittent Furosemide Infusion
B: Intervention Type: DRUG; Name: Beta-blockers including Carvedilol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: ACE inhibitors; Assigned to Arm(s): N/A
C: Intervention Type: DEVICE; Name: Aquadex system; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: IV diuretic; Assigned to Arm(s): N/A
D: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Drug: loop diuretic | Arm Label: Usual care plus tolvaptan; Type: ACTIVE_COMPARATOR; Interventions: Drug: loop diuretic, Drug: tolvaptan | Arm Label: ultrafiltration; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ultrafiltration | Intervention Type: DRUG; Name: loop diuretic; Assigned to Arm(s): Usual care plus tolvaptan, usual care | Intervention Type: DRUG; Name: tolvaptan; Assigned to Arm(s): Usual care plus tolvaptan | Intervention Type: PROCEDURE; Name: ultrafiltration; Assigned to Arm(s): ultrafiltration

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
Brief Summary: Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when Oxytocin isn't available. The aim of this study is to compare the safety and efficacy of Oxytocin and misoprostol for prevention of PPH.


Options:
A: Arm Label: TXA; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): TXA | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin
C: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: UnijectTM; Type: EXPERIMENTAL; Interventions: Device: UnijectTM | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DEVICE; Name: UnijectTM; Assigned to Arm(s): UnijectTM
D: Arm Label: Syntocinon; Type: ACTIVE_COMPARATOR; Interventions: Drug: Syntocinon | Arm Label: Carbetocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Syntocinon; Assigned to Arm(s): Syntocinon | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
Brief Summary: Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when Oxytocin isn't available. The aim of this study is to compare the safety and efficacy of Oxytocin and misoprostol for prevention of PPH.


Options:
A: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin
B: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: PLACEBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol, PLACEBO
C: Arm Label: intravenous & intramuscular oxytocin; Type: EXPERIMENTAL; Interventions: Procedure: after delivery of the fetus & when anterior shoulder seen | Arm Label: after delivery & when anterior shoulder seen; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravenous & intramuscular oxytocin | Intervention Type: DRUG; Name: intravenous & intramuscular oxytocin; Assigned to Arm(s): after delivery & when anterior shoulder seen | Intervention Type: PROCEDURE; Name: after delivery of the fetus & when anterior shoulder seen; Assigned to Arm(s): intravenous & intramuscular oxytocin
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging
Brief Summary: Prostate cancer has been the most common cancer in men in Finland over the last ten years. Prostate-specific antigen (PSA) plays an important role in screening of prostate cancer. However, PSA has a limited sensitivity and specificity for prostate cancer detection. Commonly, the diagnosis of prostate cancer is done by transrectal ultrasonography (TRUS) guided biopsy. Due to the low accuracy of TRUS, a systematic biopsy is usually performed instead of targeted TRUS biopsy. As biopsy carries a risk of increase in complications, there is an increasing interest in developing more accurate non-invasive imaging modalities.

This study will enroll 150 men with clinical suspicion of prostate cancer due to higher serum level of PSA than 2.5 ng/ml and/or abnormal digital rectal examination. Multiparametric magnetic resonance imaging (mpMRI) at 3 Tesla (T) magnetic field using surface coils will be used to non-invasively predict the presence or absence of prostate cancer. Targeted TRUS guided biopsy based on MRI findings will be performed in addition to routine twelve core TRUS biopsy. Moreover, selected serum and urine biomarkers as well as biomarkers extracted from fresh biopsy sample will be collected and correlated with the presence or absence of prostate cancer.


Options:
A: Intervention Type: PROCEDURE; Name: Prostate HistoScanning; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Multi-parametric MRI; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Transperineal prostate mapping biopsy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Image guided biopsies; Assigned to Arm(s): N/A
B: Arm Label: All cohorts (prostate biopsy percutaneous biopsy and ablation); Type: EXPERIMENTAL; Interventions: Device: EM Tracking | Intervention Type: DEVICE; Name: EM Tracking; Assigned to Arm(s): All cohorts (prostate biopsy percutaneous biopsy and ablation)
C: Arm Label: Prostate biopsy; Type: OTHER; Interventions: Procedure: Prostate biopsy | Intervention Type: PROCEDURE; Name: Prostate biopsy; Assigned to Arm(s): Prostate biopsy
D: Arm Label: MRI; Type: EXPERIMENTAL; Interventions: Device: 3T MRI (Magnetom Verio 3T, Erlangen, Germany), Device: Transrectal ultrasound (Bk Medical Pro Focus Ultraview 2202 system) | Intervention Type: DEVICE; Name: 3T MRI (Magnetom Verio 3T, Erlangen, Germany); Assigned to Arm(s): MRI | Intervention Type: DEVICE; Name: Transrectal ultrasound (Bk Medical Pro Focus Ultraview 2202 system); Assigned to Arm(s): MRI

Answer: D